Cargando…

Antagonism of the Thromboxane‐Prostanoid Receptor as a Potential Therapy for Cardiomyopathy of Muscular Dystrophy

BACKGROUND: Muscular dystrophy (MD) causes a progressive cardiomyopathy characterized by diffuse fibrosis, arrhythmia, heart failure, and early death. Activation of the thromboxane‐prostanoid receptor (TPr) increases calcium transients in cardiomyocytes and is proarrhythmic and profibrotic. We hypot...

Descripción completa

Detalles Bibliográficos
Autores principales:	West, James D., Galindo, Cristi L., Kim, Kyungsoo, Shin, John Jonghyun, Atkinson, James B., Macias‐Perez, Ines, Pavliv, Leo, Knollmann, Bjorn C., Soslow, Jonathan H., Markham, Larry W., Carrier, Erica J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898850/ https://www.ncbi.nlm.nih.gov/pubmed/31662020 http://dx.doi.org/10.1161/JAHA.118.011902

Ejemplares similares

Translating golden retriever muscular dystrophy microarray findings to novel biomarkers for cardiac/skeletal muscle function in Duchenne Muscular Dystrophy
por: Galindo, Cristi L., et al.
Publicado: (2015)

Myocardial strain imaging in Duchenne muscular dystrophy
por: Earl, Conner C., et al.
Publicado: (2022)

The role of thromboxane prostanoid receptor signaling in gastric ulcer healing
por: Yamane, Sakiko, et al.
Publicado: (2021)

Increased Number of Circulating CD8/CD26 T Cells in the Blood of Duchenne Muscular Dystrophy Patients Is Associated with Augmented Binding of Adenosine Deaminase and Higher Muscular Strength Scores
por: Soslow, Jonathan H., et al.
Publicado: (2017)

T1 mapping is abnormal before decline in EF in patients with Becker and Duchenne muscular dystrophy
por: Soslow, Jonathan H, et al.
Publicado: (2013)

Assessing Physical Activity Using Accelerometers in Youth with Duchenne Muscular Dystrophy
por: Arteaga, David, et al.
Publicado: (2020)

Regional 4D Cardiac Magnetic Resonance Strain Predicts Cardiomyopathy Progression in Duchenne Muscular Dystrophy
por: Earl, Conner C., et al.
Publicado: (2023)

Duchenne Muscular Dystrophy Patients: Troponin Leak in Asymptomatic and Implications for Drug Toxicity Studies
por: Sheybani, Aryaz, et al.
Publicado: (2022)

Left ventricular function by echocardiography correlates poorly with cardiac MRI measures in Duchenne muscular dystrophy
por: Soslow, Jonathan H, et al.
Publicado: (2014)

Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy
por: Raucci, Frank J., et al.
Publicado: (2021)

Thromboxane prostanoid signaling in macrophages attenuates lymphedema and facilitates lymphangiogenesis in mice: TP signaling and lymphangiogenesis
por: Mishima, Toshiaki, et al.
Publicado: (2023)

Myocardial T1 and T2 Mapping in Duchenne muscular dystrophy: characterization of late gadolinium Eenhancement
por: Soslow, Jonathan H, et al.
Publicado: (2016)

Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy
por: Soslow, Jonathan H., et al.
Publicado: (2016)

Full and Partial Agonists of Thromboxane Prostanoid Receptor Unveil Fine Tuning of Receptor Superactive Conformation and G Protein Activation
por: Capra, Valérie, et al.
Publicado: (2013)

Role of E-type prostaglandin receptor EP3 in the vasoconstrictor activity evoked by prostacyclin in thromboxane-prostanoid receptor deficient mice
por: Li, Zhenhua, et al.
Publicado: (2017)

Expression of the TPα and TPβ isoforms of the thromboxane prostanoid receptor (TP) in prostate cancer: clinical significance and diagnostic potential
por: Mulvaney, Eamon P., et al.
Publicado: (2016)

Localized strain characterization of cardiomyopathy in Duchenne muscular dystrophy using novel 4D kinematic analysis of cine cardiovascular magnetic resonance
por: Earl, Conner C., et al.
Publicado: (2023)

Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel
por: Spurney, Christopher F, et al.
Publicado: (2021)

Natural History of Cardiomyopathy in Adult Dogs With Golden Retriever Muscular Dystrophy
por: Guo, Lee‐Jae, et al.
Publicado: (2019)

Mineralocorticoid receptor antagonism by finerenone is sufficient to improve function in preclinical muscular dystrophy
por: Lowe, Jeovanna, et al.
Publicado: (2020)

GRMD cardiac and skeletal muscle metabolism gene profiles are distinct
por: Markham, Larry W., et al.
Publicado: (2017)

Cardiac Dysrhythmias, Cardiomyopathy and Muscular Dystrophy in Patients with Emery-Dreifuss Muscular Dystrophy and Limb-Girdle Muscular Dystrophy Type 1B
por: Hong, Jong-Seo, et al.
Publicado: (2005)

Endothelial Extracellular Signal‐Regulated Kinase/Thromboxane A2/Prostanoid Receptor Pathway Aggravates Endothelial Dysfunction and Insulin Resistance in a Mouse Model of Metabolic Syndrome
por: Sato, Atsushi, et al.
Publicado: (2022)

The BDNF rs6265 Polymorphism is a Modifier of Cardiomyocyte Contractility and Dilated Cardiomyopathy
por: Raucci, Frank J., et al.
Publicado: (2020)

Physiology and pathophysiology of prostanoid receptors
por: Narumiya, Shuh
Publicado: (2007)

Vascular-targeted therapies for Duchenne muscular dystrophy
por: Ennen, James P, et al.
Publicado: (2013)

Saying NO to muscular dystrophy
por: Dove, Alan W.
Publicado: (2001)

Fatigue in muscular dystrophies
por: Angelini, Corrado, et al.
Publicado: (2012)

Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism
por: Al-Khalidi, Rasha, et al.
Publicado: (2018)

RNAseq analysis for the diagnosis of muscular dystrophy
por: Gonorazky, Hernan, et al.
Publicado: (2015)

Thromboxane Modulates Endothelial Permeability
por: Klausner, J. M., et al.
Publicado: (1994)

Stability of thromboxane in blood samples
por: Helgadóttir, Helga, et al.
Publicado: (2019)

Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy
por: Barp, Andrea, et al.
Publicado: (2015)

A Pilot Study of Tranilast for Cardiomyopathy of Muscular Dystrophy
por: Matsumura, Tsuyoshi, et al.
Publicado: (2017)

Echocardiographic Features of Cardiomyopathy in Emery-Dreifuss Muscular Dystrophy
por: Marchel, Michał, et al.
Publicado: (2021)

Prostanoid Receptors in the Human Vascular Wall
por: Norel, Xavier
Publicado: (2007)

Prostanoid Metabolites as Biomarkers in Human Disease
por: Idborg, Helena, et al.
Publicado: (2022)

The Link between Prostanoids and Cardiovascular Diseases
por: Beccacece, Livia, et al.
Publicado: (2023)

Inhibition of FLT1 ameliorates muscular dystrophy phenotype by increased vasculature in a mouse model of Duchenne muscular dystrophy
por: Verma, Mayank, et al.
Publicado: (2019)

Longitudinal Study of Three microRNAs in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
por: Trifunov, Selena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_el0ip9o33p0942aarr9hg77s1e